“Not what the doctor ordered” (August 24) is a great editorial, offering focused suggestions to improve the scope and implementation of the new pharma policy.
The government must not grab the power vested with the regulator; that could kill the very purpose of a regulator. Equally important is the editorial comment, “Direct price control is a backward-looking strategy.” Strict control on the functioning of chemists and a sharp eye on fake drugs are other crucial aspects.
Greater emphasis on the quality of drugs and standards of production facilities is extremely important not only for the well-being of the people but also to
